CORDIS call2021

HORIZON-HLTH-2021-DISEASE-04

HORIZON-HLTH-2021-DISEASE-04

Programme
HORIZON
Funded projects (dataset)
39
EU contribution (sum)
€263,175,129
Portal deadline

Leading topic in historical projects: HORIZON-HLTH-2021-DISEASE-04-04

Start here

Suggested partners for this call

Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.

Top coordinators

Organisations that coordinated the most funded projects under this call.

Organisations strong on this topic

Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).

Frequent collaborators

Pairs that often appear together in the same funded project under this call.

Proposal partner finder

One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.

Typical consortium pattern

Derived from historical funded projects linked to this CORDIS call in Grantibase.

Avg. orgs / project
14.92
Median orgs / project
14
Min / max orgs
629

Country presence

Participant rows (an org can appear in multiple countries if data varies).

  • Spain68
  • Germany68
  • Italy57
  • France44
  • Netherlands43
  • United Kingdom38
  • Belgium38
  • Denmark25
  • Sweden22
  • Greece19
  • Switzerland17
  • Portugal16
  • Norway12
  • Poland10
  • Austria9
  • Romania8
  • United States8
  • Ireland7

Organization types

  • university142 orgs · 205 rows
  • research_institute125 orgs · 158 rows
  • sme84 orgs · 87 rows
  • public_body35 orgs · 46 rows
  • other35 orgs · 44 rows
  • company36 orgs · 42 rows

Topics in funded projects

Related funded projects

Largest EU contributions in this call — useful to see who already won funding on similar lines.

Open full project list in advanced search

ProjectEU contribution
REPO4EU

Precision drug REPurpOsing For EUrope and the world

€22,982,612
REMEDi4ALL

BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL

€22,561,532
ADVANCE-VAC4PM

Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies

€9,999,995
NEUROCOV

The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV

€8,384,036
DUALSAVE-FGS

Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

€7,984,441
REACT

Respiratory Host-Pathogen Interaction

€7,597,250
PvSTATEM

SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION

€7,290,778
HORUS

Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation

€7,136,103
EChiLiBRiST

Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival

€6,935,381
EPIVINF

Epigenetic regulation of host factors in viral infections (EPIVINF)

€6,932,308
HERVCOV

SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients

€6,846,157
D-SOLVE

Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D

€6,754,010
UNDINE

The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

€6,718,139
Long Covid

Decision support for prediction and management of Long Covid Syndrome (LCS)

€6,549,674
AInCP

clinical validation of Artificial Intelligence for providing a personalized motor clinical profile assessment and rehabilitation of upper limb in children with unilateral Cerebral Palsy

€6,494,092